Johnson & Johnson earnings... Last week, the FDA asked states to halt J&J's one-shot Covid vax, after six people developed rare blood clotting. It could be a blow to the rollout — but Dr. Fauci predicts J&J's shot will return by Friday. Earnings drop tomorrow, but don't expect a major boost from vax sales: unlike Moderna and Pfizer, J&J pledged to sell its vaccine "at cost" (read: no profit).
Snap drops earnings... Thursday. In February, Snap excited investors by saying it expects 50% annual sales growth for the next few years. But it's still unprofitable (and earns 10X less revenue per user than Facebook). Snap has been focused on growing ad revenue in non-messaging features. We'll see if it grew ads in Snap Maps, Discover, and its TikTok copycat “Spotlight."